Related Experiment Video
Updated: May 1, 2026
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
[Expression of bcl-2, c-erbB2, and p53 protein in cervical epithelial carcinogenesis]
Zhong-Hui Tang1, Qing-Fa Cai, Xing-An Ye
1Department of Pathology, Faculty of Preclinical Medicine, Putian College, Putian, Fujian, 351100, PR China. tzh6409@peoplemail.com.cn
Background & Objective:
Less research of molecular biology have been reported on cervical carcinogenesis. So the authors designed this study to evaluate the expression and clinical significance of antiapoptosis gene bcl-2, oncogene c-erbB2, and tumor suppressor gene p53 in the progression of this kind of cancer.
Methods:
Using S-P immunohistochemical technique, the authors examined the expression of bcl-2, c-erbB2, and p53 in 48 squamous cell carcinoma of the cervix, 42 cervical intraepithelial neoplasia (CIN), and 20 normal cervical tissues.
Results:
The expression rates of bcl-2, c-erbB2, and p53 were 72.9%(35/48), 60.4% (29/48), and 58.3% (28/48) in carcinomas, 61.9% (26/42), 38.1% (16/42), and 26.2% (11/42) in CIN, 20.0% (4/20), 0.0% (0/20), and 0.0% (0/20) in normal cervices, respectively. The overexpression of bcl-2 protein in carcinomas and in CIN was remarkably higher than that in normal cervices (P< 0.01), and the difference between carcinomas and CIN was not significant (P>0.05). There were significant differences for c-erbB2 and p53 between carcinomas and CIN and normal cervices, respectively (P< 0.05). There were significant differences for bcl-2, c-erbB2, and p53 between CIN3 and CIN1-2, respectively (P< 0.05). Expression of bcl-2 and p53 were correlated with histological type, tumor grades, and clinical stages (P< 0.05). Expression of bcl-2 was lower keratinized than nonkeratinized and was lower as tumor grades and clinical stages increased (P< 0.05). It was not associated with lymph node metastasis (P >0.05). However, the expression of p53 was contrary with bcl-2. Expression of c-erbB2 was not associated with histological type, tumor grades, clinical stages, and lymph node metastasis (P >0.05).
Conclusion:
In cervical carcinogenesis, the overexpression of bcl-2 protein may be activated in the early stage of pathogenesis of cervical carcinoma. Expression of c-erbB2 was the signal of cell malignant change. Expression of p53 was associated with the pathogenesis and development of cervical carcinoma.
Related Concept Videos
02:23Abnormal Proliferation
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:31The Intrinsic Apoptotic Pathway